Article

Statins May Not be Associated with a Reduction in Primary Cardiovascular Events in Patients with Systemic Lupus Erythematosus

2026-06-30

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Importance</h4> Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE), due to both traditional CVD risk factors and SLE specific factors. Although statins are first-line therapy for primary prevention of CVD in the general population, it is unclear whether statins protect against first time cardiovascular events (CVEs)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fe362faf-ba23-5df2-9ba7-df89948184a2
DOI: 10.64898/2026.06.26.26356369

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Statins May Not be Associated with a Reduction in Primary Cardiovascular Events in Patients with Systemic Lupus ErythematosusDOI 10.64898/2026.06.26.26356369Read

Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus.Semantic proximity Read

Cardiovascular Risk in Systemic Lupus Erythematosus: A Cross-Sectional Analysis of NHANES 2001–2023Semantic proximity Read

Association between Systemic Lupus Erythematosus and Coronary Heart Disease: a retrospective case-control analysis and Mendelian Randomization StudySemantic proximity Read

Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.Semantic proximity Read

Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune DisordersSemantic proximity Read

THE STATE OF CURRENT MANAGEMENT OF THE HEIGHTENED RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR EVENTS IN AN ESTABLISHED COHORT OF PATIENTS WITH LUPUS ERYTHEMATOSUSSemantic proximity Read

Systemic Lupus Erythematosus and Cardiovascular Disease: A Mendelian Randomization Study.Semantic proximity Read

Systemic lupus erythematosus-accelerated atherosclerosis: mechanistic insights and clinical implications.Semantic proximity Read

Exploring the Causal Link Between Systemic Lupus Erythematosus and Stroke Risk Through Mendelian Randomization Study.Semantic proximity Read

Cardiovascular Consequences of Autoimmune Rheumatic Diseases.Semantic proximity Read

Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.Semantic proximity Read

Dose-dependent oral glucocorticoid cardiovascular risk in people with immune-mediated inflammatory diseasesSemantic proximity Read